Supports gentle care for sensitive, delicate skin
Evidence does not support treating those broad marketing claims as established medical benefits
10.1186/s13054-020-03158-0 Summary Keywords COVID-19, cytokine release syndrome, MIS-C, TNF- inhibitor, infliximab Citation Guo Y, Hu K, Li Y, Lu C, Ling K, Cai C, Wang W and Ye D (2022) Targeting TNF- for COVID-19: Recent Advanced and Controversies
Useful angiogenesis endpoints include: VEGF expression VEGFR2 pathway markers CD34 staining factor VIII staining endothelial cell response new vessel organisation blood flow related tissue markers A 2009 study looked at BPC-157 in relation to VEGF expression and angiogenic behaviour across cell culture and tissue injury models
PEG 540 (blend)
The ionic liquid additives including 1-butyl-3-methylimidazolium (BMIMBF 4 ) and 1-butyl-1-methylpiperidinium tetrafluoroborate ([BMP] + [BF 4 ] ) suppressed ion migration and formation of I 2 at the GBs (Fig